Marzenna Sekulska

Statistics

Publications

Citations

3.7K

H-Index

Active since

1998

Affiliations

Estudios Clínicos Latinoamérica(Current)

Université Laval

Iuliu Hațieganu University of Medicine and Pharmacy

Population Health Research Institute

Technische Universität Dresden

Marzenna Sekulska is an author at Estudios Clínicos Latinoamérica specializing in diabetes pharmacotherapy, type 2 diabetes mellitus treatment, and type 2 diabetes endocrinology.

Publications per year

1998–2019

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.

J. Bodalski, K. Mianowska, W Niewiarowski et al. · Pharmacy World & Science · 1998 · 33 citations

Veterinary Medicine, Genetics, Pharmacology +14

1–3 of 3